Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

INFORLIFE

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 30
  • 0 comments

FDA approve MIDAZOLAM

Comment Full text

EXELA PHARMA

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 26
  • 0 comments

FDA approve MIDAZOLAM

Comment Full text

ALNYLAM PHARMS INC

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 29
  • 0 comments

FDA approve PATISIRAN SODIUM

Comment Full text

NEURELIS INC

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 30
  • 0 comments

FDA approve DIAZEPAM

Comment Full text

UCB INC

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 28
  • 0 comments

FDA approve MIDAZOLAM

Comment Full text

ACACIA

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 29
  • 0 comments

FDA approve REMIMAZOLAM BESYLATE

Comment Full text

LUNDBECK PHARMS LLC

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 26
  • 0 comments

FDA approve CLOBAZAM

Comment Full text

HIKMA

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 27
  • 0 comments

FDA approve LORAZEPAM

Comment Full text

HERITAGE PHARMS INC

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 31
  • 0 comments

FDA approve AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE

Comment Full text

BAUSCH

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 30
  • 0 comments

FDA approve LORAZEPAM

Comment Full text
  • Previous
  • 901
  • 902
  • 903
  • 904
  • 905
  • Next

Search

News categories

  • Technical Exchange News(14775)
  • Event(6229)
  • SEC News(398991)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(243097)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin